Real-time continuous glucose monitoring vs. self-monitoring of blood glucose: cost-utility in South Korean type 2 diabetes patients on intensive insulin
For individuals with T2D managed by intensive insulin therapy in South Korea, rt-CGM is cost-effective relative to SMBG.
Authors
- Hamza Alshannaq (ORCID: https://orcid.org/0000-0003-3952-1113)
- Sabrina Ilham
- Gregory J. Norman (ORCID: https://orcid.org/0000-0001-7989-9597)
- Richard Fulton Pollock (ORCID: https://orcid.org/0000-0002-9873-7507)
- Sang‐Man Jin
- Jae Hyeon Kim (ORCID: https://orcid.org/0000-0001-5001-963X)
- Ji Yoon Kim
- Waqas Ahmed (ORCID: https://orcid.org/0000-0002-9035-7614)
Institutions
- Samsung Medical Center (KR)
- Health Economics and Outcomes Research (United Kingdom) (GB)
- Dexcom (United States) (US)
- Covalence Research
- Sungkyunkwan University (KR)
- University of Cincinnati Medical Center (US)
Publication Details
- Journal
- Journal of Medical Economics
- Published
- 2024-09-14
- DOI
- https://doi.org/10.1080/13696998.2024.2405293
- Citations
- 10
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 3.58